NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,
The latest breakthroughs for Alzheimer's and dementia theweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theweek.com Daily Mail and Mail on Sunday newspapers.
Research calls for greater investment in Alzheimer's clinical trials europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
2024: Learning Year for Alzheimer's Drug Development miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.